Avicanna Closes Non-Brokered Private Placement Raising $3.9 Million and Announces Warrant Repricing
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…
Pharmaceuticals, Biotechnology and Life Sciences
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…
NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) — Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) (the “Company”), a gene-editing…
DEVON, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid…
SOUTH SAN FRANCISCO, Oct. 19, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for…
David Millan, PhD, VP of Chemistry, to present overview of company’s proprietary protein degrader platform and its clinical stage asset,…
LEXINGTON, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing…
MENLO PARK, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly…
PITTSBURGH, Oct. 19, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for…
Sandusky, OH, Oct. 19, 2021 (GLOBE NEWSWIRE) — PAO Group, Inc. (OTC Pink: PAOG) yesterday announced the launch of its…
1) Layout Ad Image for Oct 19 PR The layout of the Tauri-Gum™ Digital Ad Display This Campaign is Focused on…